Specific Serum Ig Recognizing Staphylococcal Wall Teichoic Acid Induces Complement-Mediated Opsonophagocytosis against Staphylococcus aureus
暂无分享,去创建一个
M. Matsushita | K. Kurokawa | B. Lee | Shinji Takahashi | Kazue Takahashi | Jang-Hyun An | Dong-Jun Jung | Min‐Jung Kim | Y. Aoyagi | Hee-Seung Lee | Y. Jung
[1] Seulggie Choi,et al. Identification of staphylococcal lipoteichoic acid-binding proteins in human serum by high-resolution LTQ-Orbitrap mass spectrometry. , 2012, Molecular immunology.
[2] L. Trouw,et al. Complement activation by (auto-) antibodies. , 2011, Molecular immunology.
[3] John D Lambris,et al. Complement: a key system for immune surveillance and homeostasis , 2010, Nature Immunology.
[4] K. Kurokawa,et al. Inhibitory Role for d-Alanylation of Wall Teichoic Acid in Activation of Insect Toll Pathway by Peptidoglycan of Staphylococcus aureus , 2010, The Journal of Immunology.
[5] M. Matsushita,et al. Human Serum Mannose-binding Lectin Senses Wall Teichoic Acid Glycopolymer of Staphylococcus aureus, Which Is Restricted in Infancy* , 2010, The Journal of Biological Chemistry.
[6] R. Möllby,et al. Levels of Antibody against 11 Staphylococcus aureus Antigens in a Healthy Population , 2010, Clinical and Vaccine Immunology.
[7] T. Kohler,et al. The wall teichoic acid and lipoteichoic acid polymers of Staphylococcus aureus. , 2010, International journal of medical microbiology : IJMM.
[8] K. Kurokawa,et al. Shuttle vectors derived from pN315 for study of essential genes in Staphylococcus aureus. , 2010, Biological & pharmaceutical bulletin.
[9] K. Shimizu,et al. Auxiliary role for d‐alanylated wall teichoic acid in Toll‐like receptor 2‐mediated survival of Staphylococcus aureus in macrophages , 2010, Immunology.
[10] M. Levine,et al. Immunology of combining CRM(197) conjugates for Streptococcus pneumoniae, Neisseria meningitis and Haemophilus influenzae in Chilean infants. , 2009, Vaccine.
[11] J. Nicolás,et al. Is mannose-binding lectin deficiency associated with infection due to Gram-positive bacteria? , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[12] K. Kurokawa,et al. Pleiotropic Roles of Polyglycerolphosphate Synthase of Lipoteichoic Acid in Growth of Staphylococcus aureus Cells , 2008, Journal of bacteriology.
[13] M. Boermeester,et al. Low Serum Mannose-Binding Lectin Level Increases the Risk of Death due to Pneumococcal Infection , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[14] C. Weidenmaier,et al. Teichoic acids and related cell-wall glycopolymers in Gram-positive physiology and host interactions , 2008, Nature Reviews Microbiology.
[15] Timothy Foster,et al. Key Role for Clumping Factor B in Staphylococcus aureus Nasal Colonization of Humans , 2008, PLoS medicine.
[16] J. Y. Kim,et al. Mannose‐binding lectin without the aid of its associated serine proteases alters lipopolysaccharide‐mediated cytokine/chemokine secretion from human endothelial cells , 2007, Immunology.
[17] O. Schneewind,et al. Synthesis of glycerol phosphate lipoteichoic acid in Staphylococcus aureus , 2007, Proceedings of the National Academy of Sciences.
[18] C. Kaito,et al. Colony Spreading in Staphylococcus aureus , 2006, Journal of bacteriology.
[19] J. Dengjel,et al. Staphylococcus aureus Deficient in Lipidation of Prelipoproteins Is Attenuated in Growth and Immune Activation , 2005, Infection and Immunity.
[20] B. Kocsis,et al. Comparison of Antibody Repertoires against Staphylococcus aureus in Healthy Individuals and in Acutely Infected Patients , 2005, Clinical Diagnostic Laboratory Immunology.
[21] T. Fujita,et al. Role of L-Ficolin/Mannose-Binding Lectin-Associated Serine Protease Complexes in the Opsonophagocytosis of Type III Group B Streptococci1 , 2005, The Journal of Immunology.
[22] A. Fattom,et al. Safety and immunogenicity of a booster dose of Staphylococcus aureus types 5 and 8 capsular polysaccharide conjugate vaccine (StaphVAX) in hemodialysis patients. , 2004, Vaccine.
[23] B. Neumeister,et al. Role of teichoic acids in Staphylococcus aureus nasal colonization, a major risk factor in nosocomial infections , 2004, Nature Medicine.
[24] D. Jack,et al. Enhancement of Complement Activation and Opsonophagocytosis by Complexes of Mannose-Binding Lectin with Mannose-Binding Lectin-Associated Serine Protease After Binding to Staphylococcus aureus1 , 2002, The Journal of Immunology.
[25] T. Fujita. Evolution of the lectin–complement pathway and its role in innate immunity , 2002, Nature Reviews Immunology.
[26] M. G. Finn,et al. Click Chemistry: Diverse Chemical Function from a Few Good Reactions. , 2001, Angewandte Chemie.
[27] M. Walport,et al. Complement. Second of two parts. , 2001, The New England journal of medicine.
[28] M. Walport. Complement. First of two parts. , 2001, The New England journal of medicine.
[29] M. Melbye,et al. Acute respiratory tract infections and mannose-binding lectin insufficiency during early childhood. , 2001, JAMA.
[30] D. Jack,et al. Mannose-Binding Lectin Binds to a Range of Clinically Relevant Microorganisms and Promotes Complement Deposition , 2000, Infection and Immunity.
[31] William Wiley Navarre,et al. Surface Proteins of Gram-Positive Bacteria and Mechanisms of Their Targeting to the Cell Wall Envelope , 1999, Microbiology and Molecular Biology Reviews.
[32] A. Conde. Staphylococcus aureus infections. , 1998, The New England journal of medicine.
[33] B. Söderquist,et al. Antibody response in Staphylococcus aureus septicaemia--a prospective study. , 1998, Journal of medical microbiology.
[34] Wiklund Ra,et al. First of two parts , 1997 .
[35] D. Coggon,et al. Prospective cohort study of predictors of incident low back pain in nurses , 1997, BMJ.
[36] J. Kornblum,et al. Synthesis of staphylococcal virulence factors is controlled by a regulatory RNA molecule. , 1993, The EMBO journal.
[37] S. Thiel,et al. ASSOCIATION OF LOW LEVELS OF MANNAN-BINDING PROTEIN WITH A COMMON DEFECT OF OPSONISATION , 1989, The Lancet.
[38] S. Morrison,et al. Segmental flexibility and complement fixation of genetically engineered chimeric human, rabbit and mouse antibodies. , 1988, The EMBO journal.
[39] M. Brüggemann,et al. Human monoclonal IgG isotypes differ in complement activating function at the level of C4 as well as C1q , 1988, The Journal of experimental medicine.
[40] M. Neuberger,et al. Comparison of the effector functions of human immunoglobulins using a matched set of chimeric antibodies , 1987, The Journal of experimental medicine.
[41] S. A. Hedström,et al. A new serological assay for Staphylococcus aureus infections: detection of IgG antibodies to S. aureus lipase with an enzyme-linked immunosorbent assay. , 1985, The Journal of infectious diseases.
[42] H. Verbrugh,et al. Opsonization of encapsulated Staphylococcus aureus: the role of specific antibody and complement. , 1982, Journal of immunology.
[43] H. Verbrugh,et al. Phagocytosis and killing of staphylococci by human polymorphonuclear and mononuclear leucocytes. , 1978, Journal of clinical pathology.
[44] A. Michael,et al. Dichotomy between opsonization and serum complement activation by encapsulated staphylococci , 1978, Infection and Immunity.
[45] P. Peterson,et al. Influence of encapsulation on staphylococcal opsonization and phagocytosis by human polymorphonuclear leukocytes , 1978, Infection and immunity.
[46] J. Ravetch,et al. Fcγ receptors as regulators of immune responses , 2008, Nature Reviews Immunology.
[47] J. Ravetch,et al. Fcgamma receptors as regulators of immune responses. , 2008, Nature reviews. Immunology.
[48] R. Dziarski,et al. Isolation of peptidoglycan and soluble peptidoglycan fragments. , 1994, Methods in enzymology.
[49] K. Joiner,et al. Complement and bacteria: chemistry and biology in host defense. , 1984, Annual review of immunology.